Depressive Disorder: Clinical Trials

4,479 trials for Depressive Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2627 completed, 548 unknown, 534 recruiting, 249 terminated. 2004 Not applicable, 651 Phase 2, 532 Phase 3, 433 Phase 4, 292 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2004Completed 1057, Recruiting 305, Unknown 296, Not yet recruiting 117, Terminated 79, Active not recruiting 70, Withdrawn 47, Enrolling by invitation 22, Suspended 11
Phase 2651Completed 416, Recruiting 69, Terminated 59, Unknown 45, Withdrawn 23, Not yet recruiting 19, Active not recruiting 16, Enrolling by invitation 2, Suspended 2
Phase 3532Completed 381, Terminated 47, Recruiting 40, Withdrawn 19, Unknown 18, Active not recruiting 13, Not yet recruiting 11, Suspended 2, Enrolling by invitation 1
Phase 4433Completed 280, Unknown 61, Terminated 31, Recruiting 25, Withdrawn 19, Not yet recruiting 12, Active not recruiting 3, Enrolling by invitation 1, Suspended 1
Phase 1292Completed 202, Recruiting 19, Terminated 18, Unknown 18, Withdrawn 16, Active not recruiting 8, Not yet recruiting 8, Enrolling by invitation 2, Suspended 1
Early Phase 141Completed 16, Unknown 11, Recruiting 5, Active not recruiting 2, Not yet recruiting 2, Terminated 2, Withdrawn 2, Enrolling by invitation 1

Follow Depressive Disorder: new trials by email Literature Review of Depressive Disorder trials Research Report on Depressive Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
Semaglutide (SEMA), Exercise module, Anti-inflammatory diet module - Severe Mental Illness, Depression / Major Depressive Disorder
Not applicableNot yet recruitingLudwig-Maximilians - University of Munich1402028-10-012026-05-14
Whole-Body Hyperthermia for Mood and Anxiety Disorders
Whole-Body Hyperthermia, fMRI - Postpartum Depression, Mood Disorders
Not applicableNot yet recruitingWeill Medical College of Cornell University2402028-06-012026-06-23
ACT for Veterans With IBD and Mental Health Challenges
Acceptance and Commitment Therapy - Inflammatory Bowel Diseases, Crohn's Disease
Not applicableNot yet recruitingVA Office of Research and Development502028-01-012026-02-09
iMORE+ Study: A Multi-Omics Cohort Study of Major Depressive Disorder
Major Depressive Disorder (MDD)
Not yet recruitingShanghai Mental Health Center1502027-09-012026-08-03
Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
bupropion hydrobromide, Placebo - Major Depressive Disorder
Phase 4Not yet recruitingBausch Health Americas, Inc.2462027-07-012026-09-29
Evaluation of the Acceptability, Feasibility and Exploration of the Efficacy of an Integrated Care Pathway CARIBOU
CARIBOU Integrated Care Pathway, Treatment as Usual (TAU) - Major Depressive Disorder (MDD)
Not applicableNot yet recruitingUniversidad de los Andes, Chile722027-07-012026-10-20
Stony Brook Medicine Anti-Inflammatory Trial
Celecoxib, Minocycline - Major Depressive Disorder
Phase 4Not yet recruitingStony Brook University422027-06-012026-04-23
Efficacy of a Personalized, Response-based Transdiagnostic Intervention for Emotional Disorders Delivered Via the Internet: A Protocol for an Adaptive Randomized Controlled Trial
UJI Online Transdiagnostic Protocol, UJI On Line Transdiagnostic Hibrid Protocol - Emotional Disorders, Anxiety
Not applicableNot yet recruitingUniversitat Jaume I3662027-05-012026-05-27
A Mobile Health Intervention to Improve Psychosocial Functioning in Veterans With Posttraumatic Stress Disorder and Depression Symptoms
Self-Guided STAIR Coach with Real-Time Assessment, Real-Time Assessment - Psychosocial Functioning, Stress Disorders, Post-Traumatic
Not applicableNot yet recruitingVA Office of Research and Development402027-04-012026-10-06
Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders, Major Depressive Disorder is Suspected to Have the Greatest Burden by 2030,Kynurenine Pathway is Major Route Through Which the Essential Amino Acid Tryptophan is Metabolised and Activated in Time of Stress and Immune Activation.
Major Depressive Disorder (MDD)
Not yet recruitingSohag University902027-03-142026-08-20
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
Psilocybin - Treatment Resistant Depression, Substance Use Disorders
Phase 1 / Phase 2Not yet recruitingIndiana University502027-02-012026-10-23
A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients
PDC-1421 Capsule - Major Depressive Disorder
Phase 1 / Phase 2Not yet recruitingBioLite, Inc.122027-01-152026-04-20
Qualitative Study of Student Financial Insecurity and Psychiatry
Semi-structured interviews - Depressive Disorder, Generalized Anxiety Disorder
Not yet recruitingAssistance Publique - Hôpitaux de Paris302027-01-012026-08-05
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
repetitive transcranial magnetic stimulation (rTMS) - Schizophrenia, Bipolar Disorder
Not applicableNot yet recruitingCentral South University4002027-01-012026-03-04
The SPARK-PMDD Study
Premenstrual Dysphoric Disorder, PMDD
Not yet recruitingKing's College London1202027-01-012026-08-18
Postpartum Care in the NICU Multi-Site
Postpartum Doula Support in the NICU - Postpartum, Postpartum Depression (PPD)
Not applicableNot yet recruitingChildren's Hospital of Philadelphia7562027-01-012026-10-14
Augmented Depression Therapy (ADepT) Case Series
Augmented Depression Therapy (ADepT) - Depression / Major Depressive Disorder
Not applicableNot yet recruitingOhio State University402027-01-012026-10-15
Effect of Neurofeedback and TMS
Repetitive Transcranial Magnetic Stimulation, Alpha-down EEG Neurofeedback - Depression - Major Depressive Disorder
Not applicableNot yet recruitingMassachusetts General Hospital202027-01-012026-10-23
Psilocybin for Depression in Veterans
Psilocybin, modafinil, zolpidem - Major Depression
Phase 2Not yet recruitingVA Office of Research and Development1502027-01-012026-10-26
Feasibility, Acceptability, and Preliminary Effectiveness of Cognitive Behavioral Therapy for Depression in Autistic Youth in Clinical Settings
CBT-DAY (Cognitive Behavioral Therapy for Depression in Autistic Youth), Treatment-as-Usual (TAU) - Autism Spectrum Disorder, Depressive Disorder
Not applicableNot yet recruitingChildren's Hospital Los Angeles1402026-12-012026-08-10

Showing 20 of 4479. Sign in to see all of them.

Narrower conditions

Depressive Disorder, Major (2963)  ·  Depression (1510)  ·  Depression, Postpartum (560)  ·  Depressive Disorder, Treatment-Resistant (447)  ·  Anxiety Disorders (374)  ·  Bipolar Disorder (329)  ·  Mood Disorders (190)  ·  Schizophrenia (145)  ·  Mental Disorders (141)  ·  Stress Disorders, Post-Traumatic (128)  ·  Psychological Well-Being (96)  ·  Psychotic Disorders (88)  ·  Suicidal Ideation (79)  ·  Generalized Anxiety Disorder (77)

Broader conditions

Mental Disorders (4338)  ·  Mood Disorders (4289)  ·  Behavior (1757)  ·  Behavioral Symptoms (1561)  ·  Urogenital Diseases (588)  ·  Female Urogenital Diseases and Pregnancy Complications (576)  ·  Pregnancy Complications (555)  ·  Puerperal Disorders (548)  ·  Pathological Conditions, Signs and Symptoms (427)  ·  Bipolar and Related Disorders (326)  ·  Nervous System Diseases (295)  ·  Signs and Symptoms (248)  ·  Pathologic Processes (212)  ·  Neurologic Manifestations (179)

Interventions

Escitalopram (193)  ·  Ketamine (153)  ·  Transcranial Magnetic Stimulation (144)  ·  Sertraline (108)  ·  Therapeutics (102)  ·  Duloxetine Hydrochloride (98)  ·  Cognitive Behavioral Therapy (97)  ·  Fluoxetine (77)  ·  Transcranial Direct Current Stimulation (69)  ·  Vortioxetine (66)  ·  Bupropion (60)  ·  Venlafaxine Hydrochloride (56)  ·  Psilocybin (55)  ·  Paroxetine (54)  ·  Citalopram (52)

Sponsors

Massachusetts General Hospital (104)  ·  National Institute of Mental Health (NIMH) (82)  ·  New York State Psychiatric Institute (70)  ·  GlaxoSmithKline (68)  ·  Centre for Addiction and Mental Health (62)  ·  Eli Lilly and Company (60)  ·  Stanford University (59)  ·  Janssen Research & Development, LLC (53)  ·  Shanghai Mental Health Center (45)  ·  VA Office of Research and Development (40)  ·  Mclean Hospital (38)  ·  University of California, Los Angeles (38)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (37)  ·  AstraZeneca (35)  ·  H. Lundbeck A/S (35)

Countries

United States (2039)  ·  Canada (432)  ·  China (271)  ·  Germany (239)  ·  France (200)  ·  United Kingdom (157)  ·  Spain (138)  ·  Turkey (Türkiye) (104)  ·  Poland (98)  ·  Taiwan (87)  ·  Australia (84)  ·  Sweden (81)  ·  Israel (77)  ·  South Korea (77)  ·  Denmark (75)

Top investigators

Maurizio Fava, MD (15)  ·  Carlos A Zarate, M.D. (13)  ·  Hesheng Liu, Ph.D. (11)  ·  Jenna Hoogerheyde (11)

Results publications

PMID 34817851, PMID 25758058, PMID 39428602, PMID 34510411, PMID 26644956, PMID 26709542, PMID 34183490, PMID 42383885, PMID 24816198, PMID 29140227, PMID 24067192, PMID 24175720, PMID 24571916, PMID 26474010, PMID 30508090, PMID 27685842, PMID 27780334, PMID 31577867, PMID 31818787, PMID 33128208, PMID 34131914, PMID 36708956, PMID 23485955, PMID 23497790, PMID 26644957, PMID 27488181, PMID 29608461, PMID 32242018, PMID 32860422, PMID 34235612, PMID 34286512, PMID 34874888, PMID 37656180, PMID 38819882, PMID 11556941, PMID 17074942, PMID 21731833, PMID 22106941, PMID 23106023, PMID 23146246, PMID 23216998, PMID 23585997, PMID 23585999, PMID 23673347, PMID 23982301, PMID 24127687, PMID 24766999, PMID 25271445, PMID 27035159, PMID 29282469

NIH funding

2008 (15), 2023 (13), 2025 (13), 2019 (12), 2014 (11), 2018 (11), 2016 (10), 2015 (8), 2017 (7), 2009 (3), R25DA020537 (3), 2005 (2), 271201100006I-0-27100007-1 (2), 5UH3NS103550 (2), K23MH076049 (2)